# Bioavailability and Pharmacodynamics of EPA and DHA From Fortified Soymilk and Capsules

> **NCT05802797** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Ohio State University Comprehensive Cancer Center** · enrollment: 24 (estimated)

## Conditions studied

- Healthy Diet

## Interventions

- **OTHER:** Algae Oil Fortified Soymilk
- **DIETARY_SUPPLEMENT:** Algae Oil Capsule

## Key facts

- **NCT ID:** NCT05802797
- **Lead sponsor:** Ohio State University Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-04-03
- **Primary completion:** 2026-07-10
- **Final completion:** 2026-07-10
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05802797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05802797, "Bioavailability and Pharmacodynamics of EPA and DHA From Fortified Soymilk and Capsules". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05802797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*